HIV and AIDS Epidemic in Kenya: An Overview: Special Issue on Clinical Pharmacy

Rodgers Lupia, Shu-Chen Chien

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Kenya is home to one of the world's worst HIV and AIDS epidemics. Approximately 1.5 million people are living with HIV, and an estimated 1 million children have been orphaned by the virus. The prevalence peaked in 2000 and, according to the latest figures (2010), has dramatically dropped to around 6.3%. Although many people in Kenya are still not being reached with HIV prevention and treatment services, access to treatment is increasing. More than half of adults who need treatment are receiving it, with around 100,000 additional adults on treatment in 2010 than in 2009. In comparison, the number of infected children receiving antiretroviral treatment is extremely low. Around 170,000 children are eligible to receive treatment, yet only around 1 in 5 has access to it. The knowledge and tools for preventing HIV transmission are available worldwide, but AIDS control in Kenya is apt to be for naught unless strong efforts are implemented toward the reduction of poverty, ignorance, and in the control of other common sexually transmitted diseases. In this review, we provide an overview of the impact of HIV and AIDS in Kenya, and then discuss the various strategies that have been used to address the scourge.
Original languageEnglish
Pages (from-to)231-234
Number of pages4
JournalJournal of Experimental and Clinical Medicine
Volume4
Issue number4
DOIs
Publication statusPublished - Aug 2012

Fingerprint

Kenya
Acquired Immunodeficiency Syndrome
HIV
Therapeutics
Poverty
Sexually Transmitted Diseases
HIV-1
Viruses

Cite this

HIV and AIDS Epidemic in Kenya: An Overview : Special Issue on Clinical Pharmacy. / Lupia, Rodgers; Chien, Shu-Chen.

In: Journal of Experimental and Clinical Medicine, Vol. 4, No. 4, 08.2012, p. 231-234.

Research output: Contribution to journalArticle

@article{6102849be1744da286b7c9823435e812,
title = "HIV and AIDS Epidemic in Kenya: An Overview: Special Issue on Clinical Pharmacy",
abstract = "Kenya is home to one of the world's worst HIV and AIDS epidemics. Approximately 1.5 million people are living with HIV, and an estimated 1 million children have been orphaned by the virus. The prevalence peaked in 2000 and, according to the latest figures (2010), has dramatically dropped to around 6.3{\%}. Although many people in Kenya are still not being reached with HIV prevention and treatment services, access to treatment is increasing. More than half of adults who need treatment are receiving it, with around 100,000 additional adults on treatment in 2010 than in 2009. In comparison, the number of infected children receiving antiretroviral treatment is extremely low. Around 170,000 children are eligible to receive treatment, yet only around 1 in 5 has access to it. The knowledge and tools for preventing HIV transmission are available worldwide, but AIDS control in Kenya is apt to be for naught unless strong efforts are implemented toward the reduction of poverty, ignorance, and in the control of other common sexually transmitted diseases. In this review, we provide an overview of the impact of HIV and AIDS in Kenya, and then discuss the various strategies that have been used to address the scourge.",
keywords = "AIDS, antiretroviral drugs (ARVs), antiretroviral therapy (ART), HIV, Kenya, Malawi",
author = "Rodgers Lupia and Shu-Chen Chien",
year = "2012",
month = "8",
doi = "10.1016/j.jecm.2012.06.007",
language = "English",
volume = "4",
pages = "231--234",
journal = "Journal of Experimental and Clinical Medicine",
issn = "1878-3317",
publisher = "Elsevier Taiwan LLC",
number = "4",

}

TY - JOUR

T1 - HIV and AIDS Epidemic in Kenya: An Overview

T2 - Special Issue on Clinical Pharmacy

AU - Lupia, Rodgers

AU - Chien, Shu-Chen

PY - 2012/8

Y1 - 2012/8

N2 - Kenya is home to one of the world's worst HIV and AIDS epidemics. Approximately 1.5 million people are living with HIV, and an estimated 1 million children have been orphaned by the virus. The prevalence peaked in 2000 and, according to the latest figures (2010), has dramatically dropped to around 6.3%. Although many people in Kenya are still not being reached with HIV prevention and treatment services, access to treatment is increasing. More than half of adults who need treatment are receiving it, with around 100,000 additional adults on treatment in 2010 than in 2009. In comparison, the number of infected children receiving antiretroviral treatment is extremely low. Around 170,000 children are eligible to receive treatment, yet only around 1 in 5 has access to it. The knowledge and tools for preventing HIV transmission are available worldwide, but AIDS control in Kenya is apt to be for naught unless strong efforts are implemented toward the reduction of poverty, ignorance, and in the control of other common sexually transmitted diseases. In this review, we provide an overview of the impact of HIV and AIDS in Kenya, and then discuss the various strategies that have been used to address the scourge.

AB - Kenya is home to one of the world's worst HIV and AIDS epidemics. Approximately 1.5 million people are living with HIV, and an estimated 1 million children have been orphaned by the virus. The prevalence peaked in 2000 and, according to the latest figures (2010), has dramatically dropped to around 6.3%. Although many people in Kenya are still not being reached with HIV prevention and treatment services, access to treatment is increasing. More than half of adults who need treatment are receiving it, with around 100,000 additional adults on treatment in 2010 than in 2009. In comparison, the number of infected children receiving antiretroviral treatment is extremely low. Around 170,000 children are eligible to receive treatment, yet only around 1 in 5 has access to it. The knowledge and tools for preventing HIV transmission are available worldwide, but AIDS control in Kenya is apt to be for naught unless strong efforts are implemented toward the reduction of poverty, ignorance, and in the control of other common sexually transmitted diseases. In this review, we provide an overview of the impact of HIV and AIDS in Kenya, and then discuss the various strategies that have been used to address the scourge.

KW - AIDS

KW - antiretroviral drugs (ARVs)

KW - antiretroviral therapy (ART)

KW - HIV

KW - Kenya

KW - Malawi

UR - https://www.scopus.com/record/display.uri?eid=2-s2.0-84865741422&origin=resultslist&sort=plf-f&src=s&st1=HIV+and+AIDS+Epidemic+in+Kenya&nlo=&nlr=&nls=&sid=6e2c5e819c72ec2abdd7a78d1de2dcc7&sot=b&sdt=b&sl=45&s=TITLE-ABS-KEY%28HIV+and+AIDS+Epidemic+in+Kenya%29&relpos=65&citeCnt=4&searchTerm=

UR - https://www.scopus.com/results/citedbyresults.uri?sort=plf-f&cite=2-s2.0-84865741422&src=s&imp=t&sid=46570864c43a424e055d394aad10a365&sot=cite&sdt=a&sl=0&origin=recordpage&editSaveSearch=&txGid=b14fd98163d6d3d7ced4370bc7d7ec1a

U2 - 10.1016/j.jecm.2012.06.007

DO - 10.1016/j.jecm.2012.06.007

M3 - Article

VL - 4

SP - 231

EP - 234

JO - Journal of Experimental and Clinical Medicine

JF - Journal of Experimental and Clinical Medicine

SN - 1878-3317

IS - 4

ER -